European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift作者机构：Fédération d'Hépatologie Service d'Hépato-gastroentérologieCHU Limoges
出 版 物：《World Journal of Hepatology》 (世界肝病学杂志（英文版）（电子版）)
年 卷 期：2018年第10卷第10期
页 面：639-644页
学科分类：10[医学]
主 题：French European Hepatitis C Guidelines Pangenotypic Direct acting antiviral drugs Eradication People who inject drugs Migrants
摘 要：The latest Association Fran?aise pour l Etude du Foie-French Association for Study of the Liver(AFEF) and European Association for the Study of the Liver(EASL) recommendations announce a change of paradigm, for the management of patients infected with hepatitis C virus(HCV). The AFEF recommendations focus on the elimination of HCV infection on a national level by preventing reinfection, in less than ten years. This goal involves the facilitation of patients management in a simplified pathway by increasing screening procedures and access to pangenotypic treatments mainly in the reservoir population of people who inject drugs and migrants. Even in the complex pathway of patients with previous comorbidities, AFEF takes the option of a therapeutic simplification. The EASL guidelines position themselves on the state of the art with a precise description of all therapeutic options available, without separating simplified and complex pathways even if they take into account the epidemiological evolution of difficult-to-treat populations.
维普期刊数据库
